UBS Group’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.69M | Sell |
2,782,070
-196,540
| -7% | -$204K | ﹤0.01% | 5115 |
|
|
2025
Q4 | $2.86M | Buy |
2,978,610
+976,275
| +49% | +$1.38M | ﹤0.01% | 4615 |
|
|
2025
Q3 | $3.48M | Sell |
2,002,335
-443,136
| -18% | -$868K | ﹤0.01% | 4414 |
|
|
2025
Q2 | $5.11M | Buy |
2,445,471
+1,019,616
| +72% | +$1.96M | ﹤0.01% | 3857 |
|
|
2025
Q1 | $2.43M | Buy |
1,425,855
+304,303
| +27% | +$1.14M | ﹤0.01% | 4537 |
|
|
2024
Q4 | $5.66M | Buy |
1,121,552
+937,539
| +509% | +$4.64M | ﹤0.01% | 3690 |
|
|
2024
Q3 | $1M | Buy |
184,013
+60,210
| +49% | +$397K | ﹤0.01% | 4655 |
|
|
2024
Q2 | $594K | Buy |
123,803
+29,618
| +31% | +$154K | ﹤0.01% | 4873 |
|
|
2024
Q1 | $293K | Buy |
94,185
+9,231
| +11% | +$31K | ﹤0.01% | 5586 |
|
|
2023
Q4 | $241K | Buy |
84,954
+51,538
| +154% | +$132K | ﹤0.01% | 5646 |
|
|
2023
Q3 | $97.9K | Buy |
33,416
+433
| +1% | +$1.43K | ﹤0.01% | 5841 |
|
|
2023
Q2 | $94.3K | Buy |
32,983
+12,399
| +60% | +$44.7K | ﹤0.01% | 6052 |
|
|
2023
Q1 | $63.6K | Buy |
20,584
+17,470
| +561% | +$49.7K | ﹤0.01% | 6265 |
|
|
2022
Q4 | $6.57K | Sell |
3,114
-6,713
| -68% | -$20.4K | ﹤0.01% | 9017 |
|
|
2022
Q3 | $32K | Buy |
9,827
+4,710
| +92% | +$18.1K | ﹤0.01% | 6796 |
|
|
2022
Q2 | $16K | Buy |
+5,117
| New | +$28.4K | ﹤0.01% | 7193 |
|
|
2022
Q1 | – | Sell |
-241,374
| Closed | -$1.75M | – | 10516 |
|
|
2021
Q4 | $1.75M | Buy |
241,374
+240,596
| +30,925% | +$2.38M | ﹤0.01% | 3856 |
|
|
2021
Q3 | $9K | Buy |
778
+237
| +44% | +$2.71K | ﹤0.01% | 8089 |
|
|
2021
Q2 | $6K | Buy |
+541
| New | +$5.57K | ﹤0.01% | 8444 |
|
|
2021
Q1 | – | Sell |
-335
| Closed | -$3K | – | 9202 |
|
|
2020
Q4 | $3K | Buy |
+335
| New | +$3.32K | ﹤0.01% | 8002 |
|
Other funds holding HUMA
VCM
AP
GPP
WP
VPM
